AGILASIL
Food supplement declared in France, declaration No 2019-6-233, decision dated 7 June 2019
AGILASIL is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- BIO MORVAN
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Flacon
- Daily dose
- 40 ml
- Directions for use
- Prendre 1 gobelet doseur de 40 ml par jour de préférence à jeun
- Objectives stated by the manufacturer (these are not authorised claims)
- Peau, Articulations
Declaration 295883, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acide orthosilicique stabilisé par de la choline | Silicium | pas de limite (données insuffisantes) | aucune dose fixée |
Additives
E551, E270, E202, E960
Other ingredients
Eau osmosée dynamisée
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.